VOYA Investment Management
SCMP

VOYA Investment Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

VOYA Investment Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,049
Closed -$216K – 2616
2017
Q4 		$216K Sell
12,049
-1,362
-10% -$16.8K ﹤0.01% 2301
2017
Q3 		$158K Hold
13,411
– – ﹤0.01% 2458
2017
Q2 		$141K Buy
13,411
+2,477
+23% +$25.2K ﹤0.01% 2501
2017
Q1 		$120K Hold
10,934
– – ﹤0.01% 2404
2016
Q4 		$148K Hold
10,934
– – ﹤0.01% 2387
2016
Q3 		$135 Hold
10,934
– – ﹤0.01% 2423
2016
Q2 		$120K Hold
10,934
– – ﹤0.01% 2437
2016
Q1 		$120K Hold
10,934
– – ﹤0.01% 2362
2015
Q4 		$189K Hold
10,934
– – ﹤0.01% 2304
2015
Q3 		$217K Hold
10,934
– – ﹤0.01% 2235
2015
Q2 		$180K Buy
+10,934
New +$190K ﹤0.01% 2515

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

VOYA Investment Management's SCMP Position: Q1 2018 in Review

VOYA Investment Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 12,049 shares — an estimated $216K sold.

VOYA Investment Management first reported a position in SCMP in Q2 2015 and held it in 11 quarters. The position peaked at $217K in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • VOYA Investment Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • VOYA Investment Management sold 12,049 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $216K.
  • VOYA Investment Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2015 and held it in 11 quarters.
  • VOYA Investment Management's Sucampo Pharmaceuticals, Inc. position peaked at $217K in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on VOYA Investment Management's 13F filing for Q1 2018, filed 15 May 2018.